Background: To evaluate the antimicrobial activity of lidocaine (LD) topical anesthetic spray against oral microflora. Methods: Antimicrobial effects of 10% LD spray were assessed against six bacterial cultures obtained from volunteers: Escherichia coli, Enterococcus faecalis, Staphylococcus aureus, Streptococcus salivarius, Streptococcus pyogenes, and Streptococcus sanguinis. The filter papers contained 50-µl LD, brain heart infusion (BHI) broth, or 0.2% chlorhexidine. Papers were placed on the cultured blood plates for 1-3 min. After the papers were removed, plates were incubated for 24 h. Bacterial growth on the contact areas was recorded as the antimicrobial score. The split mouth technique was use in for sample collection in clinical study. Filter papers soaked with either BHI broth or LD were placed on the right or left buccal mucosa for 1 min, and replaced with other papers to imprint biofilms onto the contact areas. Papers were placed on blood plates, incubated for 24 h, and antimicrobial scores were determined. Experiments were conducted for 2-and 3-min exposure times with a 1-day washout period. Results: LD exhibited bactericidal effects against E. coli, S. sanguinis, and S. salivarius within 1 min but displayed no effect against S. aureus, E. faecalis, and S. pyogenes. The antimicrobial effect of LD on oral microflora depended upon exposure time, similar to the results obtained from the clinical study (P < 0.05). LD showed 60-95% biofilm reduction on buccal mucosa. Conclusions: Antimicrobial activity of 10% LD topical anesthetic spray was increased by exposure time. The 3 min application reduced oral microflora in the buccal mucosa.
INTRODUCTION
In dentistry, local anesthesia is necessary, especially in the field of oral and maxillofacial surgery. The mechanism of local anesthetics inhibits the transmission of nerve impulses causing temporary loss of sensation at the peripheral organ supplied by the nerve until the anesthetic effect is terminated.
Local anesthetics used in dentistry are divided by structure into 3 classes: ester type, amide type, and saxitoxin and tetrodotoxin type. LD hydrochloride is an amide anesthetic that was developed for use in clinical practice to replace ester anesthetics that were associated with a higher incidence of allergic reactions due to one of their metabolites, para-amino benzoic acid (PABA).
LD has a rapid onset, moderate duration of action, and fewer complications, which facilitate its current widespread use. In clinical practice, LD is commonly used for injection at a 2% concentration. At higher concentrations, it can be used as a topical local anesthetic.
Besides pain blocking properties, antimicrobial effects of several local anesthetics containing LD have been reported [1] [2] [3] [4] [5] [6] [7] . Divergent results are due to the drug concentration, type of microorganism tested, method of study and various additives, such as preservatives or vasoconstrictive components such as epinephrine [7] [8] .
Topical local anesthetics are commonly used for application on sensitive areas for the purpose of sample collection, e.g., the cornea or the upper respiratory tract, or site of needle injection to reduce the pain. Antimicrobial properties of topical local anesthetics have been reported [2, 3, 5, 7, [9] [10] [11] [12] [13] . In a dental setting, oral injection of local anesthetics may cause tissue damage to some extent at the injection site, thereby increasing the chance of bacteremia due to numerous oral microflora [14] .
The use of an antiseptic agent prior to oral injection is still controversial. Instead of using an antiseptic agent to wipe the injection site, most dentists use the topical local anesthetic to block the pain from needle injection. This regimen is supported by the previous in vitro studies that topical anesthetic agents have shown antimicrobial effects and suggested a beneficial role in the prophylaxis of infection [5, 8, 13, 15] . In addition, the local infection or abscess at the site of injection is considered exceptional.
Because oral mucosa is commonly colonized with mixed microbial species as biofilms, the clinical antimicrobial effectiveness may vary depending upon the concentration and type of microorganisms. It is thus important to be aware of the antimicrobial effectiveness in clinical settings. The purpose of this study was to evaluate the antimicrobial effectiveness of 10% LD topical anesthetic spray against oral microflora in both laboratory and clinical settings.
MATERIALS AND METHODS

Volunteers for collection of oral microflora and clinical study
Twenty-two volunteers were recruited for this study. The BHI and CHX quadrants served as the negative (bacterial growth) and positive (no bacterial growth) controls, respectively. The antimicrobial effects at 2-and 3-min exposure times were evaluated in similar pro-Growth compared to the negative control Antimicrobial scores No growth or > 95% bacterial reduction 4 Growth density was 60-95% bacterial reduction 3 Growth density was 40-60% bacterial reduction 2 Growth density was 5-40% bacterial reduction 1 Growth density comparable to the negative control or less than 5% bacterial reduction 0 cedures. Bacterial growth on the LD quadrant was presented as the antimicrobial scores shown in Table 1 .
Each experiment was repeated twice to confirm the antimicrobial score.
In vivo antimicrobial effectiveness
Antimicrobial effectiveness of 10% LD local spray against oral microflora was assessed in vivo using the split Table 1 . After the washout period of at least 1 day, the volunteers were asked to conduct the experiment at 2 and 3 min exposure times using LD. In addition, antimicrobial effectiveness of 0.2% CHX was also assessed at the exposure time of 2 min.
Statistical analysis
The mean values of antimicrobial scores obtained from 22 volunteers at different exposure times (1, 2, and 3 min)
were analyzed by the Friedman test using SPSS version 18.0 statistical package for Windows (SPSS Inc. Chicago, IL). The significance level was considered at P < 0.05.
RESULTS
In vitro test for antimicrobial effect of 10% LD topical local anesthesia
The antimicrobial effect of 0.2% CHX and 10% LD against six bacterial species was shown in Table 2 . The in vitro results indicated that CHX could inhibit E. coli, S. salivarius, S. viridans, and S. aureus, within 1 min (> 95% reduction), but it had no effect against E. faecalis and S. pyogenes even after an exposure time of 3 min.
LD was less effective than CHX; within 3 min the growth of E. coli, S. salivarius, and S. viridans was less than 50% and there was no effect against S. aureus, E. faecalis, and S. pyogenes.
Regarding oral microflora, the antimicrobial effect of LD on 22 volunteer samples was shown in Fig. 1 
Antimicrobial effectiveness of 10% LD against the oral microflora on oral mucosa
Results of antimicrobial effectiveness of 10% LD when applied on buccal mucosa were shown in Fig. 3 . The highest antimicrobial score at the exposure time of 1 min was 3 in only 1 volunteer; at 2 min, the score was 3 in 4 volunteers; and at 3 min, the score was 3 in 13
volunteers. Statistical analysis indicated the significant 
DISCUSSION
The administration of local anesthesia in dental procedures by needle injection through the oral mucosa may introduce colonized oral microflora into the blood circulation [9, 16] . Some local anesthetic injections, i.e., buccal infiltration analgesia, conventional intraligamental analgesia, and modified intraligamental analgesia, can cause bacteremia [14] . Another study has shown increases in bacterial levels in the blood stream immediately after local anesthetic injection and the level were decreased subsequently [17] . Nevertheless, antibiotic prophylaxis is recommended prior to some dental treatment, i.e., tooth extraction, root scaling to reduce bacteremia, particularly in immunocompromised patients or patients receiving immunosuppressive therapy. Previous studies reported that prophylactic penicillin G prior to tooth extractions and dental cleaning decreased bacteremia rates [18] [19] .
Several previous studies have shown that local anesthesia also possesses antimicrobial properties. The first observation was made in 1909 and followed by others which studied several anesthetic preparations used in dentistry [4] [5] [6] 8, 13, 20] . The studies were conducted in vitro using various microbial species, including oral microflora species and opportunistic pathogens. Topical anesthetics were generally applied on sensitive areas to collect samples or to the injection site in order to block pain. The antimicrobial effect of topical anesthetics in the dental field has been shown to be effective against both oral and non-oral bacteria [4, 5, 7, 9] . Using the agar disc diffusion method, Gocmen et al., compared the antimicrobial effect of 5% LD, 2.5% LD/prilocaine, and 2% mupirocin (an antimicrobial agent) against six bacterial strains: S. aureus, S. epidermidis, S. pyogenes, E. faecalis, Pseudomonas aeruginosa, and E. coli [13] .
Both topical local anesthetics were found to be effective against S. aureus, S. epidermidis, E. coli, and S. pyogenes, whereas they had no effects on P. aeruginosa. Only 5% LD was effective against E. faecalis. However, the inhibition zones of both anesthetics were smaller than those of mupirocin. Other suggested mechanisms are the dysfunction of cellular respiration, or the alteration of DNA, RNA, and protein synthesis [20, 22] .
In conclusion, this study demonstrated the antimicrobial activity of 10% LD topical anesthetic spray in vitro and determined its application on buccal mucosa for 3 min could cause a reduction in oral microflora. The antimicrobial effect of local anesthetic use in dentistry may explain the low incidence of local infections and injection abscesses. The factors which interfered with the effectiveness in vivo are the drug concentration, the dilution by saliva, contact time, the number and type of microorganisms present and the presence of mucus. The suggested use of an antiseptic mouthwash to reduce oral bacteria may enhance the antimicrobial effectiveness of subsequent applications of local anesthetic spray. In addition, the use of antibiotic prophylaxis and antiseptic agents in immunocompromised patients should be considered to prevent infections by opportunistic pathogens.
